Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bluetail Medical Group is a leading provider of regenerative medicine and sports medicine treatments. The group has pioneered the use of platelet-rich plasma and regenerative cell therapies for orthopedic conditions since its founding in 2004. It is currently running an FDA Investigational Device Exemption (IDE) pivotal study on bone marrow concentrate for knee osteoarthritis. Treatments are minimally invasive alternatives to surgery with a focus on joint preservation and rapid recovery
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bluetail Medical Group.